Telmibite-MT 25+40 Tablet ER

Name: Telmibite-MT 25+40 Tablet ER
Brand: Razenta pharmaceuticals Pvt Ltd
Price: 108 INR

Prescription Required

Marketer

Razenta pharmaceuticals Pvt Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Telmibite-MT 25+40 Tablet ER

Telmibite-MT 25+40 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication daily with food at the same time, as directed by your physician. Continued use is crucial, even if you feel well, as hypertension is often asymptomatic. Discontinuing treatment may worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a healthy diet, complement this medication's effects. Adhere strictly to your doctor's instructions. Potential side effects include headache, weakness, dizziness, low blood pressure, hyperkalemia, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood glucose, kidney function, urea, and electrolytes may be necessary. Inform your doctor about any pre-existing liver or kidney issues, and pregnant or breastfeeding women should seek medical advice before starting this treatment. Always disclose all other medications, particularly those for hypertension or heart conditions.

Uses of Telmibite-MT 25+40 Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telmibite-MT 25+40 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmibite-MT 25+40 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

Common Side effects of Telmibite-MT 25+40 Tablet ER:

Headache
Weakness
Dizziness
Cold extremities
Slow heart rate
Increased potassium level in blood
Decreased blood pressure
Orthostatic hypotension (sudden lowering of blood pressure on standing)
Breathlessness
Vomiting
Abdominal pain

How to use Telmibite-MT 25+40 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Telmibite-MT 25+40 Tablet ER with a meal.

How Telmibite-MT 25+40 Tablet ER works:

Telmisartan and Metoprolol Succinate, combined as Telmibite-MT 25+40 Extended-Release tablets, offer a dual approach to hypertension management.

SAFETY ADVICE

AlcoholUNSAFE

Combining Telmibite-MT 25+40 Tablet ER and alcohol is unsafe.

PregnancyCONSULT YOUR DOCTOR

Extended-release Telmibite-MT 25+40 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingSAFE IF PRESCRIBED

Extended-release Telmibite-MT 25+40 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingUNSAFE

Taking Telmibite-MT 25+40 Extended-Release tablets might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.

KidneySAFE IF PRESCRIBED

For patients with kidney disease, Telmibite-MT 25+40 Extended-Release tablets are considered safe. No dosage alteration is necessary for Telmibite-MT 25+40 Extended-Release tablets in this patient population.

LiverCAUTION

Patients with hepatic impairment should use Telmibite-MT 25+40 Extended-Release tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Telmibite-MT 25+40 Tablet ER :

Should you forget to take a Telmibite-MT 25+40 Tablet ER, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telmibite-MT 25+40 Tablet ER

Label	Value
Developing Habits	No.
Treatment Category	Heart

FAQs on Telmibite-MT 25+40 Tablet ER

Dizziness is a possible side effect of Telmibite-MT 25+40 Tablet ER Succinate, particularly when standing up quickly after sitting or lying down. To minimize this risk, rise slowly from a lying or sitting position.

Telmibite-MT 25+40 Tablet ER Succinate works best when combined with a healthy lifestyle. Quitting smoking significantly reduces your risk of heart attack and stroke. Weight management, through diet and exercise, is crucial. A diet rich in fruits and vegetables, alongside regular physical activity, strengthens your heart and lowers your risk of heart attack.

Continue taking Telmibite-MT 25+40 Tablet ER as prescribed, even if you feel healthy. Abruptly stopping this medication can cause severe complications, including heart attack or stroke.

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.

MRP 125

13% off

108

Inclusive of all taxes

Quantity:

of Tablet ER

Telmibite-MT 25+40 Tablet...

108